This cluster shows that many adults with intellectual disability take strong pills for behavior, not for illness. The studies say behavior analysts can help cut these pills by teaching staff new skills and giving people more choices. When teams use ABA instead of medicine, doses go down and people stay safer. A BCBA can lead these efforts and protect clients from side effects.
Common questions from BCBAs and RBTs
Very common. Studies from the United Kingdom, Germany, and Australia show that over half of adults with intellectual disabilities in community settings take psychotropic medications. Most prescriptions are off-label and driven by challenging behavior rather than a diagnosed psychiatric condition.
Yes. When behavioral supports address the function of challenging behavior, the behavior decreases and the behavioral case for maintaining medication weakens. Staff training programs combined with behavioral strategies have doubled medication reduction rates in some settings.
Research shows adults with intellectual disabilities in more restrictive settings are medicated for behavior more often. Supporting people to have more choice, more autonomy, and more community access reduces the conditions that drive challenging behavior, which in turn reduces the pressure to prescribe.
A simple daily behavior rating in green, yellow, or red format is enough. Research shows that prescribers who receive this kind of ongoing behavioral data are more likely to reduce medications after stable positive periods. Make it easy for caregivers to carry the rating to every appointment.
Behavioral supports need to be strong enough to address the function of the challenging behavior before tapering begins. This means a clear behavior support plan, trained staff, and a communication strategy. Tapering without behavioral support typically leads to behavior returning.